XML 36 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS
9 Months Ended
Dec. 31, 2017
REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS [Abstract]  
REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS
NOTE 19. REVENUES BY PRODUCT CATEGORY AND GEOGRAPHIC REGION AND SIGNIFICANT CONCENTRATIONS

Revenue Information

The following is a summary of our revenues by product category and represents our results from continuing operations for the three and nine months ended December 31, 2017 and 2016 (in thousands).
 
  
Three Months Ended
December 31,
  
Nine Months Ended
December 31,
 
Revenues by Product Category
 
2017
  
2016
  
2017
  
2016
 
Instruments (1)
 
$
10,468
  
$
9,349
  
$
28,395
  
$
29,271
 
Consumables (2)
  
45,475
   
40,353
   
137,884
   
130,554
 
Other products (3)
  
3,727
   
3,070
   
10,503
   
9,195
 
Product sales, net
 
$
59,670
  
$
52,772
  
$
176,782
  
$
169,020
 
 

(1)
Instruments include chemistry analyzers, hematology instruments, VSpro specialty analyzers, i‑STAT analyzers and urinalysis instruments.
(2)
Consumables include reagent discs, hematology reagent kits, VSpro specialty cartridges, i‑STAT cartridges, urinalysis tests and rapid tests.
(3)
Other products include products using the Orbos process and extended maintenance agreements.
 
The following is a summary of our revenues by geographic region based on customer location and represents our results from continuing operations for the three and nine months ended December 31, 2017 and 2016 (in thousands).
 
  
Three Months Ended
December 31,
  
Nine Months Ended
December 31,
 
Revenues by Geographic Region
 
2017
  
2016
  
2017
  
2016
 
North America
 
$
46,442
  
$
41,538
  
$
140,331
  
$
135,328
 
Europe
  
9,589
   
7,999
   
26,232
   
24,390
 
Asia Pacific and rest of the world
  
3,639
   
3,235
   
10,219
   
9,302
 
Total revenues
 
$
59,670
  
$
52,772
  
$
176,782
  
$
169,020
 
 
Significant Concentrations

During the three months ended December 31, 2017, four distributors, MWI Veterinary Supply, Inc., Henry Schein, Inc., Abbott Point of Care, Inc. and Patterson Companies, Inc. accounted for 21%, 16%, 11% and 10%, respectively, of our total worldwide revenues. During the nine months ended December 31, 2017, four distributors, MWI Veterinary Supply, Inc., Henry Schein, Inc., Abbott Point of Care, Inc. and Patterson Companies, Inc., accounted for 22%, 15%, 11% and 10%, respectively, of our total worldwide revenues.

During the three months ended December 31, 2016, four distributors, MWI Veterinary Supply, Inc., Henry Schein, Inc., Abbott Point of Care, Inc. and Patterson Companies, Inc. accounted for 21%, 14%, 10% and 10%, respectively, of our total worldwide revenues. During the nine months ended December 31, 2016, four distributors, MWI Veterinary Supply, Inc., Henry Schein, Inc., Abbott Point of Care, Inc. and Patterson Companies, Inc. accounted for 20%, 14%, 11% and 10%, respectively, of our total worldwide revenues.

Concentration of credit risk with respect to accounts receivable is primarily limited to certain distributors to whom we make significant sales. Three distributors accounted for 25%, 16% and 10%, respectively, of our total receivable balance as of December 31, 2017. Three distributors accounted for 26%, 13% and 10%, respectively, of our total receivable balance as of March 31, 2017.